Hyperfine, Inc.HYPREarnings & Financial Report
Hyperfine, Inc. develops and commercializes innovative portable low-field magnetic resonance imaging (MRI) systems for medical diagnostic use. Its solutions deliver accessible, cost-effective imaging for healthcare providers across acute care, rural clinics, pediatric care, and other underserved clinical settings worldwide.
Revenue
$3.4M
Gross Profit
$1.8M
Operating Profit
$-8.9M
Net Profit
$-11.0M
Gross Margin
53.8%
Operating Margin
-259.5%
Net Margin
-320.6%
YoY Growth
-5.7%
EPS
$-0.14
Hyperfine, Inc. Q3 FY2025 Financial Summary
Hyperfine, Inc. reported revenue of $3.4M (down 5.7% YoY) for Q3 FY2025, with a net profit of $-11.0M (down 6.7% YoY) (-320.6% margin). Cost of goods sold was $1.6M, operating expenses totaled $10.8M.
Key Financial Metrics
| Total Revenue | $3.4M |
|---|---|
| Net Profit | $-11.0M |
| Gross Margin | 53.8% |
| Operating Margin | -259.5% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
Hyperfine, Inc. Q3 FY2025 revenue of $3.4M breaks down across 2 segments, led by Products at $2.9M (84.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $2.9M | 84.1% |
| Other | $546.0K | 15.9% |
Hyperfine, Inc. Revenue by Segment — Quarterly Trend
Hyperfine, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | $4.9M | $2.9M | $2.1M | $1.5M |
| Other | $436.0K | $546.0K | $568.0K | $615.0K |
Hyperfine, Inc. Annual Revenue by Year
Hyperfine, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $13.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $13.6M |
| 2024 | $12.9M |
| 2023 | $11.0M |
| 2022 | $6.8M |
Hyperfine, Inc. Quarterly Revenue & Net Profit History
Hyperfine, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $5.3M | +128.0% | $-5.9M | -111.7% |
| Q3 FY2025 | $3.4M | -5.7% | $-11.0M | -320.6% |
| Q2 FY2025 | $2.7M | -25.8% | $-9.2M | -342.2% |
| Q1 FY2025 | $2.1M | -35.1% | $-9.4M | -440.7% |
| Q4 FY2024 | $2.3M | -13.6% | $-10.4M | -447.7% |
| Q3 FY2024 | $3.6M | +56.4% | $-10.3M | -283.4% |
| Q2 FY2024 | $3.6M | +7.4% | $-10.2M | -279.7% |
| Q1 FY2024 | $3.3M | +25.0% | $-9.8M | -298.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3M | $3.6M | $3.6M | $2.3M | $2.1M | $2.7M | $3.4M | $5.3M |
| YoY Growth | 25.0% | 7.4% | 56.4% | -13.6% | -35.1% | -25.8% | -5.7% | 128.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $85.4M | $76.6M | $69.4M | $58.9M | $53.4M | $45.2M | $41.5M | $55.3M |
| Liabilities | $9.8M | $9.8M | $11.1M | $9.9M | $10.3M | $10.1M | $14.6M | $14.3M |
| Equity | $75.6M | $66.8M | $58.3M | $49.0M | $43.1M | $35.1M | $26.9M | $41.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-12.5M | $-9.4M | $-8.5M | $-8.4M | $-9.2M | $-7.9M | $-5.6M | $-5.2M |